Nephrolithiasis (kidney stones), chronic kidney disease, dialysis, kidney disease and pregnancy, cardiovascular disease
Education and Experience
BA Magna Cum Laude: St. Lawrence University 1988; MD: University of Medicine and Dentistry of New Jersey 1993; Resident: University of North Carolina 1993-1996; Chief resident: University of North Carolina 1996-1997; Nephrology Fellow: University of North Carolina 1997-1999; Clinical Instructor in Medicine 1999-2000; Assistant Professor of Medicine 2000-2011; Associate Professor of Medicine, 2011-2019; Professor of Medicine, 2019-present.
Clinical and Research Interests
Dr. Denu-Ciocca is interested in management of patients with both acute and chronic kidney disease. She has a strong interest in lipids and cardiovascular disease in this population. She participates in clinical trials in the end stage renal disease population and is the director of the Carolina Dialysis Center located in Pittsboro. Dr. Denu-Ciocca specializes in the medical management of kidney stones and has a strong interest in pregnancy and kidney disease.
Books and Book Chapters
Denu-Ciocca C. “Medical management of hypocitraturia.” In: Monga M, Penniston K, Goldbard D (eds.); Pocket Guide to Kidney Stone Prevention. Springer International Publishing; 2015, pp. 55-61.
Nachman PH, Denu-Ciocca C. “Vasculitis.” In: Lerma EV, Nissenson R, Berns JS (eds.); Current Diagnosis and Treatment in Nephrology and Hypertension. Lange CURRENT series. McGraw-Hill; 2009, pp. 265-75.
Pearle SM, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Priminger GM, Turk TM, White JR; American Uirological Association. Medical management of kidney stones: AUA guideline. J Uro9l 2014; 192(2):316-24; doi: 10.1016/j.juro.2014.05.006. PMID: 24857648.
Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-CioccaC. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Intern Pharmacother2008; 42(1):9-15. PMID: 18000162.
Finn WF, Denu-Ciocca C, Joy MS, Reddy G, Chawla S, Garsd A, Goldwater R. Double-blind, dose-ranging study of lanthanum dioxycarbonate (SPI-014, RenaZorb) in healthy volunteers shows high phosphorus binding capacity. J Am Soc Nephrol 2013; 24:756.